RE:Early exercise of warrants -> $ 867,854DKM,
“Biologic Publishing Inc. also dba Biologic Nutrigenomic Health Research Corp are the prime holder of the trial and Health Canada registration. Not Plasm Pharmaceuticals. Plasm is the joint venture with NSP and Rhema will most likely be the manufacturer of Cavaltinib for them.
My search engine found a forum post one evening that showed someone from this company looking for a “hard to find” trial access document. “User Manual for Clinical Trial Technology Services”. That led me to Parexel out of California. Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. The manual was for their Parexel informatics ClinPhone IVR system but if you follow the trail it lines up with their strategy of outsourcing this to a north American or international company, so they only have to get this trial approved and done once. Not saying this is the chosen company but Biologics nor Naturally Splendid have the resources to do this themselves and they stated on last month Stockhouse video and prior videos that they were looking for international partners to move this forward globally for them, first shot.
That forum disappeared as fast as it showed up. I saw it again another night but disappeared again and have not looked since. That is why I do not mention it. Kind of like a UFO sighting, it was there and then it was gone with lots of speculation.
As far as the trial goes. It won’t be accepted fully by the Scientific community if it is not made public pre and post trial like all the rest for Covid19. Health Canada encourages sponsors to register their clinical trials in publicly accessible registries such as ClinicalTrials.gov. to date, no sign of it anywhere.
Also, Health Canada’s clinical trial database https://health-products.canada.ca/ctdb-bdec/index-eng.jsp is managed by Health Canada and provides a source of information about Canadian clinical trials involving human pharmaceutical and biological drugs “only” but does not include information about clinical Trials related to “NHP’s” (Natural Health Products). So you wont see it there either.
As for the company, just follow the money. This will take cash, lots of it, which the NSP never seems to have readily available. Therefore, the Plasmpharma timeline and NSP $500,000.00 payment structure set out in their last Quarterly Report does not line up to a trial taking place within the stated November 4th release of 60 to 90 days+, which the two Bob’s and a Cavaltinib” stated back in November last year.
Franco has been working mostly on his Keto brand products for B-Epic since then and Curcumitol-Q for a US outfit. He has made vague references in his youtube videos to a potential trial coming for Cavaltinib with his base ingredient BDMC, but that was all he stated.
The Cavaltinib US Trademark was approved in February 2021. No formal US objections. Just paperwork to file and finish it seems.
As for your strategic shareholder. Speculation? Most likely is GEORGE RAGOGNA former “Ontario” Alternamedz owner, now Director, Chairman of the Board, NSP. (Remember, NSP was going to buy them out in 2019… and dropped that one too) Or maybe Mike Schmidt, one of the Plasm directors. Who knows…who cares! Or just some other sucker parting with his money for longer than expected like the ones before them.
As for Biologic and NSP. They are both tight lipped on the Cavaltinib Trial, which means there is a problem, or delay, or financing issue, or something a miss, between the two. Otherwise Craig would be promoting it all over the internet by now. Now with 4 real vaccines out in the market and hundreds of supplementary treatments there after, the potential for Cavaltinib has greatly diminished the huge return it could have provided us, the shareholders, who bought into this venture, all knowing of Craig’s track record.
Fool me once, shame on you; fool me twice, shame on me.
As for posting. No more after this. Broke is done…Good luck out there! Have a great day!